Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 13, 2026
EEM vs. FRDM: Weighing Broad Emerging Markets Exposure Against a Freedom-Focused Approach

EEM vs. FRDM: Weighing Broad Emerging Markets Exposure Against a Freedom-Focused Approach

Key Takeaways

  • iShares MSCI Emerging Markets ETF (EEM) provides broad passive exposure to large- and mid-cap equities across emerging markets via the MSCI Emerging Markets Index, holding approximately 1,197 securities with an expense ratio of 0.72%.
  • Freedom 100 Emerging Markets ETF (FRDM) employs a freedom-weighted strategy that prioritizes countries with higher personal, political, and economic freedom scores, resulting in a more concentrated portfolio of about 130 holdings and a lower expense ratio of 0.49%.
  • The two ETFs differ structurally in diversification and country selection: EEM offers comprehensive emerging markets coverage including significant allocations to China and other lower-freedom nations, while FRDM systematically excludes or underweights such markets.
  • Sector exposures overlap in technology and financials but diverge in emphasis, with both tilting toward information technology yet FRDM showing a more pronounced concentration in high-freedom jurisdictions such as Taiwan and South Korea.
  • Cost efficiency and thematic differentiation position FRDM as a lower-cost alternative for investors seeking filtered emerging markets exposure, whereas EEM suits those preferring maximum breadth and liquidity.
  • Performance dynamics in recent market cycles have been influenced by geopolitical developments and sector rotations, with freedom-weighted approaches demonstrating resilience through selective country allocation.

Why These Two ETFs Stand Out for Emerging Markets Exposure

Investors seeking emerging markets equity exposure face meaningful choices between broad-market and rules-based thematic strategies. The iShares MSCI Emerging Markets ETF (EEM) and Freedom 100 Emerging Markets ETF (FRDM) both target developing economies yet employ distinct methodologies that affect diversification, risk characteristics, and cost structures. EEM delivers comprehensive passive indexing across numerous countries and issuers, while FRDM applies freedom metrics to refine country weights. These ETFs do not compete directly as identical products but offer complementary or alternative paths for achieving emerging markets equity exposure aligned with different investor preferences for breadth versus selectivity.

A Closer Look at iShares MSCI Emerging Markets ETF (EEM)

The iShares MSCI Emerging Markets ETF (EEM) is a passive exchange-traded fund that seeks to track the MSCI Emerging Markets Index. It holds approximately 1,197 large- and mid-cap equities from emerging market countries. Top holdings typically include Taiwan Semiconductor Manufacturing Company, Samsung Electronics, and SK hynix, with notable representation from other Asian issuers. Sector allocations emphasize information technology (around 40%) and financials (around 20%), followed by consumer discretionary, industrials, and communication services. The fund maintains an expense ratio of 0.72% and operates as a traditional index-tracking vehicle with periodic rebalancing to match the underlying benchmark. Its structure provides high liquidity and broad diversification across more than 20 emerging markets. I also checked sector allocations using Tickeron’s AI Screener to see how EEM stacks up against peers.

Exploring Freedom 100 Emerging Markets ETF (FRDM)

The Freedom 100 Emerging Markets ETF (FRDM) tracks the Life + Liberty Freedom 100 Emerging Markets Index, which applies a freedom-weighted methodology based on personal, political, and economic freedom metrics. The fund holds roughly 130 securities, resulting in a more concentrated portfolio than broad benchmarks. Top holdings often feature Samsung Electronics, SK hynix, and Taiwan Semiconductor Manufacturing Company, with allocations favoring higher-freedom jurisdictions such as Taiwan, South Korea, and select Latin American and European emerging markets. Sector weights show elevated exposure to information technology (around 44%) and financial services (around 22%). FRDM carries an expense ratio of 0.49% and follows a rules-based rebalancing process tied to the freedom index. This thematic approach distinguishes it through systematic underweighting or exclusion of lower-scoring countries. From what I see, the lower cost stands out as a clear advantage for longer-term holders.

The Emerging Markets Landscape

Emerging markets equities remain sensitive to global macroeconomic shifts, including interest rate cycles, commodity price movements, and geopolitical tensions. Capital flows into the sector have fluctuated with U.S. monetary policy expectations and China-related developments. Regulatory changes in key markets, supply-chain realignments, and technology sector innovation continue to influence sector momentum. Broader risks encompass currency volatility, political instability in select regions, and varying corporate governance standards. Freedom-weighted strategies have gained attention amid ongoing debates over country risk and governance quality, prompting differentiation between comprehensive indexes and filtered approaches.

Performance Dynamics and Positioning

In recent market cycles, the two ETFs have exhibited divergent relative positioning driven by country allocation differences. The broad exposure in iShares MSCI Emerging Markets ETF (EEM) captures performance across a wider set of nations, including those with lower freedom scores, leading to greater sensitivity to regional-specific events. Freedom 100 Emerging Markets ETF (FRDM) has demonstrated more selective positioning through its emphasis on higher-freedom markets, which has contributed to distinct volatility profiles and sector rotation responses, particularly within technology and financial holdings. Both funds reflect earnings dynamics of major semiconductor and electronics issuers, yet FRDM’s narrower country set has produced differentiated outcomes during periods of emerging markets rotation and macro uncertainty. I cross-referenced recent performance trends with Tickeron’s AI tools to confirm the allocation impacts.

Tickeron AI Verdict

Based on observable structural factors including lower expense ratio, concentrated yet diversified holdings within higher-freedom jurisdictions, and thematic consistency, Tickeron’s AI would currently assign a higher probabilistic preference to Freedom 100 Emerging Markets ETF (FRDM) for investors prioritizing cost efficiency and selective emerging markets exposure. iShares MSCI Emerging Markets ETF (EEM) retains advantages in liquidity and maximum breadth for those seeking unmodified benchmark replication. In my view, the choice ultimately depends on whether an investor values breadth or selectivity more.

Enhancing ETF Research with Tickeron’s AI Screener

In my own analysis workflow, I often rely on Tickeron’s AI Screener to efficiently compare ETFs on factors like expense ratios, holdings concentration, and sector tilts. The platform’s customizable filters and AI-driven signals help surface relevant data quickly, which proved useful when evaluating the structural differences between EEM and FRDM. It has become a practical addition to my research routine for spotting these kinds of nuanced opportunities.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EEM, FRDM

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


EEM's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for EEM turned positive on August 03, 2026. Looking at past instances where EEM's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on EEM as a result. In of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

EEM moved above its 50-day moving average on August 12, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EEM advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

EEM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for EEM crossed bearishly below the 50-day moving average on July 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EEM entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are PDD Holdings (NASDAQ:PDD), Gold Fields Ltd (NYSE:GFI), Yum China Holdings (NYSE:YUMC), Tencent Music Entertainment Group (NYSE:TME), H World Group Limited (NASDAQ:HTHT), Vipshop Holdings Limited (NYSE:VIPS), TAL Education Group (NYSE:TAL), SLM Corp (NASDAQ:SLM).

Industry description

The investment seeks to track the investment results of the MSCI Emerging Markets Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is designed to measure equity market performance in the global emerging markets. The underlying index includes large- and mid-capitalization companies and may change over time.

Market Cap

The average market capitalization across the iShares MSCI Emerging Markets ETF ETF is 20.21B. The market cap for tickers in the group ranges from 179.73K to 126.73B. PDD holds the highest valuation in this group at 126.73B. The lowest valued company is TPIA at 179.73K.

High and low price notable news

The average weekly price growth across all stocks in the iShares MSCI Emerging Markets ETF ETF was 23%. For the same ETF, the average monthly price growth was 23%, and the average quarterly price growth was 53%. DSY experienced the highest price growth at 27%, while TME experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the iShares MSCI Emerging Markets ETF ETF was -19%. For the same stocks of the ETF, the average monthly volume growth was -42% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 43
P/E Growth Rating: 64
Price Growth Rating: 54
SMR Rating: 54
Profit Risk Rating: 82
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
EEM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category DiversifiedEmergingMkts

Profile
Details
Category
Diversified Emerging Mkts
Address
iShares, Inc.400 Howard StreetSan Francisco
Phone
N/A
Web
www.ishares.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.